Usine-AFYREN-NEOXY-fermenteurs crédits

AFYREN announces the industrial commissioning of its AFYREN NEOXY plant and publishes its 2021 Full-Year Results

AFYREN announces the industrial commissioning of its AFYREN NEOXY plant and publishes its 2021 Full-Year Results

  •  Finalization of the construction of the AFYREN NEOXY plant at cost and on time despite the health crisis context
  • Industrial commissioning of the plant with the launch of the test phase
  • Strong cash position of €67 million at the end of 2021 following the success of the IPO
  • Execution of the strategy in line with the plan presented at the IPO and confirmation of the financial outlook and objectives

Nicolas SORDET, AFYREN’s CEO, stated: “2021 was a transforming year for AFYREN, culminating in the IPO in September. The year 2022 also promises to be full of challenges and we are pleased to have met the first one with the launch of the industrial commissioning of our AFYREN NEOXY plant on the Carling Saint-Avold site, in accordance with the announced schedule and at cost. We now have the financial resources and a first industrial tool to accelerate the achievement of our Purpose, “We enable low-carbon, circular industry by providing biobased solutions built with our partners to benefit the environment”.”


Industrial commissioning of AFYREN NEOXY plant

In the second half of 2020, AFYREN launched the construction of AFYREN NEOXY, its first large-scale plant, located in Carling-Saint Avold, in the Grand Est region. AFYREN NEOXY is the first industrial-scale plant for the production of biobased carboxylic acids from sugar beet co-products.
Today, the construction phase for this plant is nearing completion: all the equipment has been delivered and the acceptance and start-up process is underway in accordance with the planned schedule. These tests will be spread out over several weeks for a gradual commissioning of the different equipment, a test phase that will prepare the launch of production.

Jean SAINT-DONAT, President of AFYREN NEOXY, adds: “The industrial commissioning of the AFYREN NEOXY plant is a key step in the history of AFYREN. We are ready to start and deliver the first batches of biobased acids developed with AFYREN technology this year. We are facing this transition to industrial scale with serenity alongside the fifty or so new employees already recruited and trained, and we are confirming our deep commitment to the environment by promoting short supply and sales channels thanks to our strategic geolocation in the heart of Europe.”


2021 key financial elements

Sales in 2021 amount to €3.04 million, against €3.99 million in 2020. The sales are essentially composed of income from the various contracts concluded with AFYREN NEOXY (patent and know-how licenses, services related to the obtaining of the BBI grant1 by AFYREN NEOXY, commercial and administrative assistance services).
As expected, the Company recorded a net loss in 2021, amounting to €3.61 million (compared to €2.13 million in 2020), as a consequence of the acceleration of investments prior to the operation of the industrial units.


Purpose and extra-financial rating significantly improved

Following several months of reflection and consultation with its internal and external stakeholders, AFYREN and its board of directors define and formalize its Purpose in early 2022: “We enable low-carbon, circular industry by providing biobased solutions built with our partners to benefit the environment.”


Full Press release:


Latest News

#INSPIRINGTALKS – Biodiversity – Interview with Marion Canale, CEO of CEARITIS

CEARITIS was created in 2020 to research biocontrol solutions. The company’s lead product is a system that protects tree crops from major pests while respecting biodiversity. AFYREN and CEARITIS, which share the same values and the same commitment to a more sustainable environment, announced at the beginning of the year their collaboration to provide arboriculturists with an innovative alternative to insecticides that respects biodiversity and is not harmful to the environment. Coming from a family of arboriculturists, Marion Canale and Solena Canale Parola founded CEARITIS to come up with a safe and nature-friendly solution to a problem they were all […]

Annual Financial Report 2022

«The highlight of 2022 was the industrial start-up and inauguration of the AFYREN NEOXY plant in Carling-Saint Avold, in the Grand Est region of France. This biorefinery, which produces biobased carboxylic acids from biomass co-products […] AFYREN is making its mark on unexplored territory with the humility of a company that is still young but whose ambition is justified by an offering that is unparalleled on an industrial scale in today’s fast-growing world market.» Stefan Borgas, Chair of the Board of Directors, and Nicolas Sordet, CEO. Read the full report on this structuring year from an industrial, commercial and extra-financial […]

AFYREN announces its 2022 annual financial results

A successful 2022 in commercial, industrial, and extra-financial terms: • Inauguration of the group’s first factory, AFYREN NEOXY • Commercial success: 75% of annual acid volume and 100% of fertilizer already pre-sold • Further improved extra-financial rating (78/100 vs. 66 published and 72 adjusted) Teams fully mobilized at the start of 2023: • Reliability testing and tuning is in progress at AFYREN NEOXY plant, and clients have confirmed commitments for orders totaling €165 million in revenue • International expansion is confirmed, with the project for a second factory in Thailand A solid financial situation at the end of 2022: • […]

AFYREN and biocontrol start-up CEARITIS announce innovative partnership

AFYREN and biocontrol start-up CEARITIS announce innovative partnership for alternative crop-protection system for orchards AFYREN and CEARITIS join forces to offer tree crop growers an alternative protection solution that respects biodiversity The biomimetic “Push&Pull” biocontrol device developed by CEARITIS creates a natural barrier against crop-destroying insects AFYREN enters organic agriculture market with agreement to supply its biobased organic acids CEARITIS plans industrial production of its sustainable biocontrol solution for tree crops, manufactured with AFYREN’s biobased acids, beginning this year  Clermont-Ferrand/Lyon, February 7, 2023, 7:45 am CET ­— AFYREN, a greentech company that offers manufacturers bio-based, low-carbon ingredients produced using unique […]

AFYREN entering a partnership project with Mitr Phol, a global leader in the sugar industry

AFYREN chooses Thailand for its second biobased organic acids plant, entering a partnership project with Mitr Phol, a global leader in the sugar industry First international project for AFYREN, as announced at the time of its IPO; This comes as its first plant starts up in France. With this project in Thailand, AFYREN is targeting the Asian market, which represents 25% of the world market for carboxylic acids. A Letter Agreement has been signed between AFYREN and Mitr Phol, the world’s third largest sugar producer, for an industrial partnership based on AFYREN’s technology. The project will take the form of […]